These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8665608)

  • 21. A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors.
    Forman BM; Yang CR; Au M; Casanova J; Ghysdael J; Samuels HH
    Mol Endocrinol; 1989 Oct; 3(10):1610-26. PubMed ID: 2558297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbA beta 1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone.
    Behr M; Ramsden DB; Loos U
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1081-7. PubMed ID: 9100577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcoma and thyroid disorders: a common etiology?
    Merimsky O; Issakov J; Kollender Y; Inbar M; Bickels J; Meller I
    Oncol Rep; 2002; 9(4):863-9. PubMed ID: 12066223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid function in poikilotherms.
    Eales JG
    Prog Clin Biol Res; 1990; 342():415-20. PubMed ID: 2200021
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mechanisms of the intracellular activities of thyroid gland hormones].
    Brtko J
    Vnitr Lek; 2006 Oct; 52(10):935-40. PubMed ID: 17063806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
    Rascle A; Ghysdael J; Samarut J
    Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
    Schroeder C; Gibson L; Beug H
    Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene.
    Usala SJ; Bale AE; Gesundheit N; Weinberger C; Lash RW; Wondisford FE; McBride OW; Weintraub BD
    Mol Endocrinol; 1988 Dec; 2(12):1217-20. PubMed ID: 2905763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.
    Usala SJ; Tennyson GE; Bale AE; Lash RW; Gesundheit N; Wondisford FE; Accili D; Hauser P; Weintraub BD
    J Clin Invest; 1990 Jan; 85(1):93-100. PubMed ID: 2153155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dominant and nondominant negative C-erbA beta 1 receptors associated with thyroid hormone resistance syndromes augment 12-O-tetradecanoyl-phorbol-13-acetate induction of the collagenase promoter and exhibit defective 3,5,3'-triiodothyronine-mediated repression.
    Ways DK; Qin W; Cook P; Parker PJ; Menke JB; Hao E; Smith AM; Jones C; Hershman JM; Geffner ME
    Mol Endocrinol; 1993 Sep; 7(9):1112-20. PubMed ID: 8247013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thyroid hormones and their precursors. II. Species-specific properties].
    Tóth G; Noszál B
    Acta Pharm Hung; 2014; 84(1):21-37. PubMed ID: 24809164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor.
    Usala SJ; Menke JB; Watson TL; Wondisford FE; Weintraub BD; Bérard J; Bradley WE; Ono S; Mueller OT; Bercu BB
    Mol Endocrinol; 1991 Mar; 5(3):327-35. PubMed ID: 1653889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of thyroid hormone action.
    Harvey CB; Williams GR
    Thyroid; 2002 Jun; 12(6):441-6. PubMed ID: 12165104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA recognition by normal and oncogenic thyroid hormone receptors. Unexpected diversity in half-site specificity controlled by non-zinc-finger determinants.
    Judelson C; Privalsky ML
    J Biol Chem; 1996 May; 271(18):10800-5. PubMed ID: 8631892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The v-erbA oncogene (review).
    Thormeyer D; Baniahmad A
    Int J Mol Med; 1999 Oct; 4(4):351-8. PubMed ID: 10493974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer promoted by the oncoprotein v-ErbA may be due to subcellular mislocalization of nuclear receptors.
    Bonamy GM; Guiochon-Mantel A; Allison LA
    Mol Endocrinol; 2005 May; 19(5):1213-30. PubMed ID: 15650025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel point mutation (R243Q) in exon 7 of the c-erbA beta thyroid hormone receptor gene in a family with resistance to thyroid hormone.
    Onigata K; Yagi H; Sakurai A; Nagashima T; Nomura Y; Nagashima K; Hashizume K; Morikawa A
    Thyroid; 1995 Oct; 5(5):355-8. PubMed ID: 8563471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of two c-erbA messenger ribonucleic acids in rat GH3 cells by thyroid hormone.
    Lazar MA; Chin WW
    Mol Endocrinol; 1988 Jun; 2(6):479-84. PubMed ID: 2901667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
    Wahlström GM; Vennström B
    Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning of a thyroid hormone-responsive Rana catesbeiana c-erbA-beta gene.
    Davey JC; Schneider MJ; Galton VA
    Dev Genet; 1994; 15(4):339-46. PubMed ID: 7923937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.